The Company has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAl) status from the US Food & Drug Administration (USFDA) for Unit IV.
from Latest News https://ift.tt/2ugn7ja
Tuesday, 18 February 2020
Aurobindo Pharma surges 19% as Unit IV receives EIR with VAI staus from FDA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment